Peters A M, Brown J, Hartnell G G, Myers M J, Haskell C, Lavender J P
Department of Diagnostic Radiology, Royal Postgraduate Medical School, Hammersmith Hospital, London.
Cardiovasc Res. 1987 Nov;21(11):830-4. doi: 10.1093/cvr/21.11.830.
This technique for non-invasive measurement of renal blood flow is based on the principle of fractionation of cardiac output, and applicable with any recirculating gamma activity tracer. It effectively determines the count rate that would be recorded over the kidney if the tracer behaved like radiolabelled microspheres and was completely trapped in the kidney on first pass. After correction for kidney depth, the estimated first pass activity plateau, expressed as a fraction of the injected dose, is equal to the kidney's fraction of cardiac output. The principle of the technique was validated by comparison with renal blood flow based on radiolabelled microspheres. Nine separate comparisons were made in two anaesthetised dogs. A known dose of 99mTc radiolabelled microspheres (particle size 23-45 microns) was injected into the left ventricle and the count rate over each kidney recorded. A known dose of 99mTc diethylenetriaminepenta acetic acid (DTPA) was then given as an intravenous bolus and the data recorded dynamically with a gamma camera online to a computer. After subtraction of the stable signal arising from the preceding radiolabelled microspheres, the theoretical first pass activity plateau from the DTPA that would have been recorded if the DTPA, after reaching the systemic circulation, had behaved like radiolabelled microspheres and become completely trapped in the renal vascular bed, was estimated. Using doses based on syringe counts before and after injection the ratio of renal blood flow values given by the two techniques (DTPA:RLMS) was 1.14 (SD 0.22) for the left kidney and 1.1(0.17) for the right. Using doses based on whole body counts, corresponding ratios were 1.05(0.11) and 1.02(0.13).(ABSTRACT TRUNCATED AT 250 WORDS)
这种无创测量肾血流量的技术基于心输出量分流原理,适用于任何循环γ活性示踪剂。它能有效确定若示踪剂表现得像放射性标记微球且首次通过时完全滞留在肾脏中,在肾脏上方记录到的计数率。校正肾脏深度后,以注射剂量的分数表示的估计首次通过活性平台期等于肾脏在心输出量中的占比。该技术原理通过与基于放射性标记微球的肾血流量进行比较得到验证。在两只麻醉犬身上进行了九次单独比较。将已知剂量的99mTc放射性标记微球(粒径23 - 45微米)注入左心室,并记录每个肾脏上方的计数率。然后静脉推注已知剂量的99mTc二乙三胺五乙酸(DTPA),并用γ相机在线动态记录数据到计算机。减去先前放射性标记微球产生的稳定信号后,估计如果DTPA到达体循环后表现得像放射性标记微球并完全滞留在肾血管床中,从DTPA理论上记录到的首次通过活性平台期。使用基于注射前后注射器计数的剂量,两种技术给出的肾血流量值之比(DTPA:RLMS),左肾为1.14(标准差0.22),右肾为1.1(0.17)。使用基于全身计数的剂量,相应比值分别为1.05(0.11)和1.02(0.13)。(摘要截断于250字)